{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T08:15:18Z","timestamp":1783584918968,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Ultrasonics"],"DOI":"10.1007\/s10396-026-01666-0","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:28:20Z","timestamp":1783582100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Superior accuracy of a novel multidimensional index integrating static and dynamic liver stiffness for hepatocellular carcinoma risk prediction in chronic hepatitis B"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7833-0576","authenticated-orcid":false,"given":"Yusuke","family":"Sano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Osakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizaburo","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Kuzuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senju","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Ichino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"1666_CR1","doi-asserted-by":"crossref","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries.","DOI":"10.1007\/978-3-031-66563-9_8"},{"key":"1666_CR2","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.1200\/JCO.2024.42.16_suppl.10573","volume":"42","author":"JM Kocarnik","year":"2024","unstructured":"Kocarnik JM, May M, Acheson A, et al. The global burden of primary liver cancer and underlying etiologies from 1990 to 2021. J Clin Oncol. 2024;42:10573.","journal-title":"J Clin Oncol"},{"key":"1666_CR3","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521\u201331.","journal-title":"N Engl J Med"},{"key":"1666_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/hep.26180","volume":"58","author":"T Hosaka","year":"2013","unstructured":"Hosaka T, Suzuki F, Kobayashi M, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology. 2013;58:98\u2013107.","journal-title":"Hepatology"},{"key":"1666_CR5","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep.26301","volume":"58","author":"GL Wong","year":"2013","unstructured":"Wong GL, Chan HL, Mak CW, et al. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology. 2013;58:1537\u201347.","journal-title":"Hepatology"},{"key":"1666_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","volume":"62","author":"GV Papatheodoridis","year":"2015","unstructured":"Papatheodoridis GV, Chan HL, Hansen BE, et al. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015;62:956\u201367.","journal-title":"J Hepatol"},{"key":"1666_CR7","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.3390\/ijms24119543","volume":"24","author":"SA MacLennan","year":"2023","unstructured":"MacLennan SA, Marra MA. Oncogenic viruses and the epigenome: how viruses hijack epigenetic mechanisms to drive cancer. Int J Mol Sci. 2023;24:9543.","journal-title":"Int J Mol Sci"},{"key":"1666_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1440-1746.2007.05054.x","volume":"23","author":"K Nouso","year":"2008","unstructured":"Nouso K, Tanaka H, Uematsu S, et al. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances. J Gastroenterol Hepatol. 2008;23:437\u201344.","journal-title":"J Gastroenterol Hepatol"},{"key":"1666_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/jvh.13843","volume":"30","author":"D Razavi-Shearer","year":"2023","unstructured":"Razavi-Shearer D, Estes C, Gamkrelidze I, et al. Cost-effectiveness of treating all hepatitis B-positive individuals in the United States. J Viral Hepat. 2023;30:718\u201326.","journal-title":"J Viral Hepat"},{"key":"1666_CR10","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898\u2013906.","journal-title":"Gastroenterology"},{"key":"1666_CR11","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1666_CR12","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa P, Darg\u00e8re D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449\u201357.","journal-title":"Hepatology"},{"key":"1666_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1148\/radiol.2523081928","volume":"252","author":"M Friedrich-Rust","year":"2009","unstructured":"Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009;252:595\u2013604.","journal-title":"Radiology"},{"key":"1666_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling RK, Patel K, Duarte-Rojo A, et al. AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81:321\u201357.","journal-title":"Hepatology"},{"key":"1666_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling RK, Duarte-Rojo A, Patel K, et al. AASLD practice guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81:672\u2013724.","journal-title":"Hepatology"},{"key":"1666_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology"},{"key":"1666_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection: comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32\u20136.","journal-title":"Hepatology"},{"key":"1666_CR18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1666_CR19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.4254\/wjh.v16.i7.1018","volume":"16","author":"JY Huang","year":"2024","unstructured":"Huang JY, Peng JY, Long HY, et al. Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: hepatitis B virus infection and transaminases should be considered. World J Hepatol. 2024;16:1018\u201328.","journal-title":"World J Hepatol"},{"key":"1666_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/hepr.13319","volume":"49","author":"H Iijima","year":"2019","unstructured":"Iijima H, Tada T, Kumada T, et al. Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices. Hepatol Res. 2019;49:676\u201386.","journal-title":"Hepatol Res"},{"key":"1666_CR21","doi-asserted-by":"crossref","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459\u2013544.","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"1666_CR22","doi-asserted-by":"crossref","unstructured":"Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology.\u00a0Japan Society of Hepatology guidelines for the management of hepatitis\u00a0B virus infection: 2019 update. Hepatol Res. 2020;50:892\u2013923.","DOI":"10.1111\/hepr.13504"},{"key":"1666_CR23","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u201364.","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"1666_CR24","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.ultrasmedbio.2018.07.008","volume":"44","author":"G Ferraioli","year":"2018","unstructured":"Ferraioli G, Wong VW, Castera L, et al. Liver ultrasound elastography: an update to the World Federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol. 2018;44:2419\u201340.","journal-title":"Ultrasound Med Biol"},{"key":"1666_CR25","first-page":"325","volume":"2013","author":"M Kudo","year":"2001","unstructured":"Kudo M, Shiina T, Moriyasu F, et al. JSUM ultrasound elastography practice guidelines: liver. J Med Ultrason. 2001;2013:325\u201357.","journal-title":"J Med Ultrason"},{"key":"1666_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1148\/radiol.2020192437","volume":"296","author":"RG Barr","year":"2020","unstructured":"Barr RG, Wilson SR, Rubens D, et al. Update to the Society of Radiologists in ultrasound liver elastography consensus statement. Radiology. 2020;296:263\u201374.","journal-title":"Radiology"},{"key":"1666_CR27","doi-asserted-by":"publisher","first-page":"e2985","DOI":"10.1097\/MD.0000000000002985","volume":"95","author":"YS Seo","year":"2016","unstructured":"Seo YS, Kim MN, Kim SU, et al. Risk assessment of hepatocellular carcinoma using transient elastography vs. liver biopsy in chronic hepatitis B patients receiving antiviral therapy. Medicine (Baltimore). 2016;95:e2985.","journal-title":"Medicine (Baltimore)"},{"key":"1666_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.21037\/atm.2017.01.28","volume":"5","author":"P Parikh","year":"2017","unstructured":"Parikh P, Ryan JD, Tsochatzis EA. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Ann Transl Med. 2017;5:40.","journal-title":"Ann Transl Med"},{"key":"1666_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2024.112448","volume":"598","author":"M Sultana","year":"2025","unstructured":"Sultana M, Islam MA, Khairnar R, et al. A guide to pathophysiology, signaling pathways, and preclinical models of liver fibrosis. Mol Cell Endocrinol. 2025;598:112448.","journal-title":"Mol Cell Endocrinol"},{"key":"1666_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1666_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17:306\u201321.","journal-title":"Nat Rev Immunol"},{"key":"1666_CR32","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3390\/jcm10091840","volume":"10","author":"S Kim","year":"2021","unstructured":"Kim S, Lee Y, Bang SM, et al. Early normalization of alanine aminotransferase during antiviral therapy reduces risk of hepatocellular carcinoma in HBV patients. J Clin Med. 2021;10:1840.","journal-title":"J Clin Med."},{"key":"1666_CR33","doi-asserted-by":"publisher","first-page":"10052","DOI":"10.12998\/wjcc.v9.i33.10052","volume":"9","author":"HQ Xu","year":"2021","unstructured":"Xu HQ, Wang CG, Zhou Q, et al. Effects of alcohol consumption on viral hepatitis B and C. World J Clin Cases. 2021;9:10052\u201363.","journal-title":"World J Clin Cases"},{"key":"1666_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.21037\/apm-20-2353","volume":"10","author":"E Zhou","year":"2021","unstructured":"Zhou E, Yang C, Gao Y. Effect of alcohol on the progress of hepatitis B cirrhosis. Ann Palliat Med. 2021;10:415\u201324.","journal-title":"Ann Palliat Med"},{"key":"1666_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/jgh.13536","volume":"32","author":"AW Chan","year":"2017","unstructured":"Chan AW, Wong GL, Chan HY, et al. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017;32:667\u201376.","journal-title":"J Gastroenterol Hepatol"},{"key":"1666_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3350\/cmh.2018.0040","volume":"25","author":"YB Lee","year":"2019","unstructured":"Lee YB, Ha Y, Chon YE, et al. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B. Clin Mol Hepatol. 2019;25:52\u201364.","journal-title":"Clin Mol Hepatol"},{"key":"1666_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3350\/cmh.2015.21.1.32","volume":"21","author":"IK Yo","year":"2015","unstructured":"Yo IK, Kwon OS, Park JW, et al. The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B. Clin Mol Hepatol. 2015;21:32\u201340.","journal-title":"Clin Mol Hepatol"},{"key":"1666_CR38","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12876-025-04194-2","volume":"25","author":"N Wang","year":"2025","unstructured":"Wang N, Wu Y, Xiao M, et al. Dynamic changes in liver stiffness measurement by 2D shear-wave elastography predict hepatocellular carcinoma in patients with chronic hepatitis B and well-controlled viremia: a retrospective study. BMC Gastroenterol. 2025;25:578.","journal-title":"BMC Gastroenterol"},{"key":"1666_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3346\/jkms.2014.29.4.570","volume":"29","author":"JK Kim","year":"2014","unstructured":"Kim JK, Ma DW, Lee KS, et al. Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agents. J Korean Med Sci. 2014;29:570\u20135.","journal-title":"J Korean Med Sci"},{"key":"1666_CR40","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12072-024-10643-z","volume":"18","author":"S Chen","year":"2024","unstructured":"Chen S, Zhou J, Wu X, et al. Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments. Hepatol Int. 2024;18:904\u201316.","journal-title":"Hepatol Int"},{"key":"1666_CR41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468\u201375.","journal-title":"Lancet"}],"container-title":["Journal of Medical Ultrasonics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-026-01666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10396-026-01666-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-026-01666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:28:21Z","timestamp":1783582101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10396-026-01666-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":41,"alternative-id":["1666"],"URL":"https:\/\/doi.org\/10.1007\/s10396-026-01666-0","relation":{},"ISSN":["1346-4523","1613-2254"],"issn-type":[{"value":"1346-4523","type":"print"},{"value":"1613-2254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yusuke Sano, Hiroko Sugiyama, Yutaka Sasaki, Keisuke Osakabe, Eizaburo Ohno, Teiji Kuzuya, Senju Hashimoto, Yoshiki Hirooka, and Naohiro Ichino declare that they have no conflicts of interest. Naoto Kawabe has received a speaker honorarium from Gilead Sciences K.K. and Kowa Company, Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}}]}}